Access to healthcare and innovative treatments is a major issue for Canada, impacting both patients' quality of life and the country's economic competitiveness. At a time when Montréal is a key hub for innovation in the life sciences, how can the city's businesses play an active role in this transformation?
Today, our healthcare system faces major challenges: longer access to treatment than in other G7 countries, increasing pressure on healthcare infrastructures, and the need to accelerate innovation to meet patients' needs. No single player can meet these challenges alone: what's needed is a collaborative approach between the biopharmaceutical industry, governments, technology companies, investors and economic decision-makers.
In this exclusive discussion with An Van Gerven, President of Pfizer Canada, we'll explore:
- Major medical advances and their potential to transform the healthcare landscape
- Treatment access challenges and their economic implications for companies and the healthcare system
- The strategic role of business in innovation and improving access to care
- Opportunities for metropolitan companies: collaborations, public-private partnerships, market attractiveness
Why attending?
- Anticipate healthcare trends: Understand how medical innovation is impacting the economy and the business world
- Discover opportunities for collaboration: Meet key players and identify potential synergies
- Position your company in the healthcare ecosystem: Take advantage of the boom in life sciences and medical technologies in Montréal.
Whether you're a business leader, investor, manager or innovator, this meeting will provide you with a strategic vision of the future of healthcare and the economic opportunities it represents for Montréal and Canada.